Access cutting-edge age-related macular degeneration treatment through this clinical trial at a research site in Glendale. Study-provided care at no cost to qualified participants.
Access age-related macular degeneration specialists in Glendale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related age-related macular degeneration treatment provided free
This study is open to people 50 years or older with an eye condition called geographic atrophy. The purpose of this study is to compare a medicine called BI 771716 with a medicine called pegcetacoplan. BI 771716 is being developed to treat people with geographic atrophy. Pegcetacoplan is a medicine already used to treat people with geographic atrophy. In this study, participants receive either BI 771716 or pegcetacoplan as injections in the eye. Participants are in the study for a little longe
Sponsor: Boehringer Ingelheim
Check if you qualify for this age-related macular degeneration clinical trial in Glendale, CA
If you're searching for age-related macular degeneration treatment options in Glendale, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Glendale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced age-related macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.